2023 Fiscal Year Research-status Report
A comprehensive investigation of the incentives and policies in the Japanese generic drug market
| Project/Area Number |
22K13423
|
|---|
| Research Institution | Waseda University |
|---|
Principal Investigator |
富 蓉 早稲田大学, 商学学術院, 准教授 (70805259)
|
|---|
| Project Period (FY) |
2022-04-01 – 2026-03-31
|
| Keywords | generic drugs |
|---|
| Outline of Annual Research Achievements |
In 2023, we investigated the importance of the interplay between physician, pharmacist, and patient in generic drug use. We aim to contribute to the existing literature by exploring several key questions: Does a closer affiliation between hospitals and pharmacies, namely hospital-based pharmacies, correlate with increased GE usage? Does the establishment of a robust patient-pharmacy rapport, often observed in community-based pharmacies, facilitate greater GE adoption? Furthermore, how do these relationships between hospitals, patients, and pharmacies differ based on pharmacy characteristics? Lastly, of significant importance, is there an interaction between hospital-pharmacy affiliations and patient-pharmacy associations in influencing GE adoption?
|
| Current Status of Research Progress |
Current Status of Research Progress
3: Progress in research has been slightly delayed.
Reason
The slight delay in the progress of this research project is due to a combination of unforeseen challenges. Particularly, coordinating schedules with interdisciplinary collaborators and securing ethical approvals proved more time-consuming than expected, as did refining the participant recruitment strategy.The lingering logistical impacts of the COVID-19 pandemic also moderately contributed to scheduling delays for key experimental procedures.
|
| Strategy for Future Research Activity |
To improve interdisciplinary coordination, a dedicated project coordinator has been assigned, digital collaboration tools have been implemented, and structured meetings now streamline communication. Also, we’ve adjusted our laboratory scheduling to be more flexible, identified alternative spaces to avoid bottlenecks, and maintained strict safety protocols to mitigate pandemic-related impacts.
|
| Causes of Carryover |
The reason for incurring the amount to be used in the next fiscal year is due to the slightly delayed progress.We will try to catch up with the originally scheduled research progress.
|
